US Representative

Andy Biggs 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 53)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7

Introduced
1/9/23  
Refer
1/9/23  
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023 This bill modifies provisions relating to federal funding for, and health insurance coverage of, abortions. Specifically, the bill prohibits the use of federal funds for abortions or for health coverage that includes abortions. Such restrictions extend to the use of funds in the budget of the District of Columbia. Additionally, abortions may not be provided in a federal health care facility or by a federal employee. Historically, language has been included in annual appropriations bills for the Department of Health and Human Services (HHS) that prohibits the use of federal funds for abortions—such language is commonly referred to as the Hyde Amendment. Similar language is also frequently included in appropriations bills for other federal agencies and the District of Columbia. The bill makes these restrictions permanent and extends the restrictions to all federal funds (rather than specific agencies). The bill's restrictions regarding the use of federal funds do not apply in cases of rape, incest, or where a physical disorder, injury, or illness endangers a woman's life unless an abortion is performed. The Hyde Amendment provides the same exceptions. The bill also prohibits qualified health plans from including coverage for abortions. Currently, qualified health plans may cover abortion, but the portion of the premium attributable to abortion coverage is not eligible for subsidies.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7035

Introduced
1/18/24  
Death Tax Repeal Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7042

Introduced
1/18/24  
RIFLE Act of 2024 Reining in Federal Licensing Enforcement Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7083

Introduced
1/25/24  
Refer
1/25/24  
RAZOR Act Restricting Administration Zealots from Obliging Raiders Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7109

Introduced
1/29/24  
Refer
1/29/24  
Report Pass
4/10/24  
Equal Representation Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7137

Introduced
1/30/24  
Refer
1/30/24  
Trafficking Survivors Relief Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7183

Introduced
2/1/24  
Refer
2/1/24  
PROTECTS Act of 2024 Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7187

Introduced
2/1/24  
Refer
2/1/24  
Protection of Women in Olympic and Amateur Sports Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7195

Introduced
2/1/24  
Protecting the Mailing of Firearms Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7207

Introduced
2/1/24  
Refer
2/1/24  
Preventing Racism in Medicare Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7216

Introduced
2/1/24  
Refer
2/1/24  
Protecting Healthcare Employee Privacy Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB70

Introduced
1/9/23  
Refer
1/9/23  
Freedom for Farmers Act of 2023 This bill abolishes the Agency for Toxic Substances and Disease Registry. This agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7031

Introduced
1/18/24  
Refer
1/18/24  
Ultrasound Informed Consent Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB71

Introduced
1/9/23  
Refer
1/9/23  
Medical Innovation Acceleration Act of 2023 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB72

Introduced
1/9/23  
Refer
1/9/23  
This bill prohibits the use of federal funds to maintain a database or collect information that can be used to identify an individual's COVID-19 (i.e., coronavirus disease 2019) vaccination status.